-
Junshi Biology and the Institute of Microbiology, Chinese Academy of Sciences announce cooperation to develop Zika virus vaccine
Time of Update: 2021-12-04
With the solid basic research capabilities of the Institute of Microbiology, Chinese Academy of Sciences, and Junshi Bio's entire industry With the strength of chain operations, both parties will accelerate the global clinical application of Zika virus vaccines, and use local innovations to contribute to disease prevention and control in China and the world!"[1] Science, 369, 1123–1128 (2020)[2] Dai, L.
-
Virus discoveries other than the new crown are rewriting the long article in Biology "Nature"
Time of Update: 2021-10-01
By 2016, scientists still need to cultivate viruses and their hosts before they can submit a new virus species and taxonomy to ICTV, with few exceptions .
-
Oncolytic virus based on synthetic biology technology applied for clinical medicine in China, Mai Meng broke the news
Time of Update: 2021-08-08
It is an innovative biotechnology company that independently designs and researches and develops gene and cell therapy based on synthetic biology technology.
Synbiotics has adopted the DBTL model to develop a variety of oncolytic viruses and cell therapy products regulated by gene circuits .
-
The Structural Biology of the Zika Virus summarizes global research progress since the outbreak of the Zika virus.
Time of Update: 2020-09-10
Recently, The Cell sub-journal, the academic journal of biochemistry research, published online a summary article by Shi I and Gao Fu, researchers at the Institute of Microbiology of the Chinese Acade